IL142748D0 - Embryonic stem cells - Google Patents

Embryonic stem cells

Info

Publication number
IL142748D0
IL142748D0 IL14274899A IL14274899A IL142748D0 IL 142748 D0 IL142748 D0 IL 142748D0 IL 14274899 A IL14274899 A IL 14274899A IL 14274899 A IL14274899 A IL 14274899A IL 142748 D0 IL142748 D0 IL 142748D0
Authority
IL
Israel
Prior art keywords
stem cells
embryonic stem
embryonic
cells
Prior art date
Application number
IL14274899A
Original Assignee
Univ Monash
Hadasit Med Res Service
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AUPP7009A priority Critical patent/AUPP700998A0/en
Priority to AUPQ2852A priority patent/AUPQ285299A0/en
Application filed by Univ Monash, Hadasit Med Res Service, Univ Singapore filed Critical Univ Monash
Priority to PCT/AU1999/000990 priority patent/WO2000027995A1/en
Publication of IL142748D0 publication Critical patent/IL142748D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
IL14274899A 1998-11-09 1999-11-09 Embryonic stem cells IL142748D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP7009A AUPP700998A0 (en) 1998-11-09 1998-11-09 Embryonic stem cells
AUPQ2852A AUPQ285299A0 (en) 1999-09-15 1999-09-15 Embryonic stem cells
PCT/AU1999/000990 WO2000027995A1 (en) 1998-11-09 1999-11-09 Embryonic stem cells

Publications (1)

Publication Number Publication Date
IL142748D0 true IL142748D0 (en) 2002-03-10

Family

ID=25645915

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14274899A IL142748D0 (en) 1998-11-09 1999-11-09 Embryonic stem cells
IL142748A IL142748A (en) 1998-11-09 2001-04-23 Embryonic stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142748A IL142748A (en) 1998-11-09 2001-04-23 Embryonic stem cells

Country Status (6)

Country Link
US (3) US6875607B1 (en)
EP (1) EP1129176A4 (en)
JP (1) JP2002529070A (en)
CA (1) CA2349415A1 (en)
IL (2) IL142748D0 (en)
WO (1) WO2000027995A1 (en)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7455983B2 (en) * 2000-01-11 2008-11-25 Geron Corporation Medium for growing human embryonic stem cells
US20020168766A1 (en) * 2000-01-11 2002-11-14 Gold Joseph D. Genetically altered human pluripotent stem cells
US7410798B2 (en) * 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
IL151170D0 (en) 2000-03-14 2003-04-10 Es Cell Int Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
US7011828B2 (en) * 2000-03-14 2006-03-14 Es Cell International Pte. Ltd. Implanting neural progenitor cells derived for human embryonic stem cells
US20030211605A1 (en) * 2001-05-01 2003-11-13 Lee Sang-Hun Derivation of midbrain dopaminergic neurons from embryonic stem cells
WO2001098463A1 (en) * 2000-06-20 2001-12-27 Es Cell International Pte Ltd Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists
EP1176189A1 (en) * 2000-07-21 2002-01-30 Fornix Biosciences N.V. Stem cell-like cells
US20030032179A1 (en) * 2000-12-06 2003-02-13 Hariri Robert J. Post-partum mammalian placenta, its use and placental stem cells therefrom
AT466089T (en) 2000-12-22 2010-05-15 Agronomique Inst Nat Rech Position-independent and tissue-specific expression of a transgenic in the milk of a transgenic animal
JP2005503759A (en) * 2001-01-24 2005-02-10 アメリカ合衆国 The method of differentiation of stem cells into pancreatic endocrine cells
ES2444548T3 (en) 2001-02-14 2014-02-25 Anthrogenesis Corporation Renovation and repopulation of cadaveric tissues and organs decellularized by stem cells
CN1636054A (en) * 2001-07-06 2005-07-06 杰龙公司 Mesenchymal cells and osteoblasts from human embryonic stem cell
US7432104B2 (en) 2001-08-06 2008-10-07 Bresgen Inc. Methods for the culture of human embryonic stem cells on human feeder cells
EP1421181A1 (en) * 2001-08-23 2004-05-26 Reliance Life Sciences Pvt., Ltd. ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES
WO2003040355A1 (en) * 2001-11-09 2003-05-15 Es Cell International Pte Ltd Characterization and isolation of subsets of human embryonic stem cells (hes) and cells associated or derived therefrom
GB2398795A (en) * 2001-12-28 2004-09-01 Cellartis Ab A method for the establishment of a pluripotent human blastocyst-derived stem cell line
US9567591B2 (en) 2003-05-15 2017-02-14 Mello Biotechnology, Inc. Generation of human embryonic stem-like cells using intronic RNA
US20090203141A1 (en) * 2003-05-15 2009-08-13 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents
GB2407821B (en) * 2002-06-05 2007-03-21 Es Cell Int Pte Ltd Stem Cells
EP1546346A4 (en) * 2002-07-23 2006-02-08 Nanodiagnostics Inc Embryonic stem cell markers and uses thereof
WO2004013606A2 (en) 2002-08-02 2004-02-12 Stratatech Corporation Species specific dna detection
US7153650B2 (en) * 2003-03-13 2006-12-26 Geron Corporation Marker system for preparing and characterizing high-quality human embryonic stem cells
US20060134596A1 (en) * 2003-05-08 2006-06-22 Anita Sjogren Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
AU2004237425B2 (en) * 2003-05-08 2010-03-04 Cellartis Ab Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
US9394538B2 (en) 2008-05-07 2016-07-19 Shi-Lung Lin Development of universal cancer drugs and vaccines
US20050106725A1 (en) * 2003-11-19 2005-05-19 Palecek Sean P. Method of reducing cell differentiation
US20080220520A1 (en) * 2003-11-19 2008-09-11 Palecek Sean P Cryopreservation of human embryonic stem cells in microwells
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
EP1743012A4 (en) * 2004-04-09 2008-08-27 Ronald S Coldstein Methods for generating neuronal cells from human embryonic stem cells and uses thereof
WO2005113749A2 (en) 2004-05-14 2005-12-01 Becton, Dickinson And Company Stem cell populations and methods of use
KR20070083559A (en) 2004-08-13 2007-08-24 더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 Compositions and methods for self-renewal and differentiation in human embryonic stem cells
US20060040389A1 (en) * 2004-08-17 2006-02-23 Murry Charles E Purified compositions of stem cell derived differentiating cells
DE102004062184B4 (en) * 2004-12-23 2013-08-01 Wolfgang Würfel Embryo-preserving production of pluripotent embryonic stem cells, stem cells thus obtained and use thereof
WO2006084314A1 (en) * 2005-02-09 2006-08-17 Australian Stem Cell Centre Limited Stem cell populations and classification system
WO2006110806A2 (en) * 2005-04-12 2006-10-19 The Trustees Of The University Of Pennsylvania Multipotent adult stem cells
WO2006117212A2 (en) 2005-05-04 2006-11-09 Develogen Aktiengesellschaft Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
CA2613369A1 (en) * 2005-06-22 2007-01-04 Geron Corporation Suspension culture of human embryonic stem cells
AU2006286149B2 (en) 2005-08-29 2012-09-13 Technion Research And Development Foundation Ltd. Media for culturing stem cells
PE20110020A1 (en) 2005-10-13 2011-01-31 Anthrogenesis Corp Immunomodulation using placental stem cells
US20070178586A1 (en) * 2005-11-09 2007-08-02 The Ohio State University Research Foundation Methods and apparatuses for growing cells
CN103113463B (en) * 2005-12-13 2015-02-18 国立大学法人京都大学 Nuclear reprogramming factor
PL2471905T3 (en) 2005-12-29 2019-08-30 Celularity, Inc. Placental stem cell populations
EP2420565B1 (en) 2006-02-23 2017-08-30 ViaCyte, Inc. Compositions and methods useful for culturing differentiable cells
US20100297087A1 (en) * 2006-04-11 2010-11-25 Nanodiagnostics Israel., Ltd Pluripotent stem cells characterized by expression of germline specific genes
US8293529B2 (en) 2006-04-28 2012-10-23 Daiichi Sankyo Company, Limited Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
US8968994B2 (en) * 2006-07-06 2015-03-03 Jeremy Micah Crook Method for stem cell culture and cells derived therefrom
EP2059586B1 (en) 2006-08-02 2016-07-20 Technion Research & Development Foundation Ltd. Methods of expanding embryonic stem cells in a suspension culture
US8785193B2 (en) * 2006-09-14 2014-07-22 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Dissection tool and methods of use
WO2008039874A2 (en) 2006-09-26 2008-04-03 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
EP2108043A4 (en) * 2007-01-18 2010-04-21 Suomen Punainen Risti Veripalv Novel methods and reagents directed to production of cells
WO2008100498A2 (en) 2007-02-12 2008-08-21 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
EP2129771B1 (en) 2007-03-26 2018-09-12 The Government of the U.S.A. as represented by the Secretary of the Department of Health & Human Services Methods for modulating embryonic stem cell differentiation
US9382515B2 (en) 2007-04-07 2016-07-05 Whitehead Institute For Biomedical Research Reprogramming of somatic cells
JP2008307007A (en) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
DK2783692T3 (en) 2007-09-28 2019-04-15 Celularity Inc Tumor suppression using humant placenta perfusate and human placenta derivative intermediate natural killer cells
US8623650B2 (en) 2007-10-19 2014-01-07 Viacyte, Inc. Methods and compositions for feeder-free pluripotent stem cell media containing human serum
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
WO2009075119A1 (en) 2007-12-10 2009-06-18 Kyoto University Effective nucleus initialization method
WO2009092092A1 (en) 2008-01-18 2009-07-23 Regents Of The University Of Minnesota Stem cell aggregates and methods for making and using
ES2722198T3 (en) * 2008-05-02 2019-08-08 Univ Kyoto Nuclear reprogramming method
WO2009152529A2 (en) 2008-06-13 2009-12-17 Whitehead Institute For Biomedical Research Nine Cambridge Center Programming and reprogramming of cells
CA2965883A1 (en) 2008-08-22 2010-02-25 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
AU2013248265B2 (en) 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
JP5390624B2 (en) 2008-11-04 2014-01-15 バイアサイト インク Stem cell assembly suspension composition and differentiation method thereof
US8956867B2 (en) * 2008-11-07 2015-02-17 Wisconsin Alumni Research Foundation Method for culturing stem cells
CN107201337A (en) 2008-11-19 2017-09-26 人类起源公司 Amnion-derived attached cell
KR101909847B1 (en) 2008-12-17 2018-12-18 더 스크립스 리서치 인스티튜트 Generation and maintenance of stem cells
AU2010276264B2 (en) 2009-07-21 2013-09-19 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
WO2011011500A1 (en) 2009-07-21 2011-01-27 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
JP5785948B2 (en) 2009-09-04 2015-09-30 ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ Methods for promoting genomic stability and telomere elongation in embryonic stem cells
WO2011037301A1 (en) * 2009-09-22 2011-03-31 서울대학교병원 Method for derivation of pluripotent stem cells from adult cells and pluripotent stem cells produced by method
CA2783437A1 (en) 2009-11-12 2011-05-19 Technion Research & Development Foundation Ltd. Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
US9121007B2 (en) 2010-01-26 2015-09-01 Anthrogenesis Corporatin Treatment of bone-related cancers using placental stem cells
EP2529008A1 (en) 2010-01-26 2012-12-05 Université Libre de Bruxelles Tools for isolating and following cardiovascular progenitor cells
AU2011220940C1 (en) 2010-02-25 2015-04-16 Abt Holding Company Modulation of angiogenesis
CA2795518A1 (en) 2010-04-07 2011-10-13 Anthrogenesis Corporation Angiogenesis using placental stem cells
TW201138792A (en) 2010-04-08 2011-11-16 Anthrogenesis Corp Treatment of sarcoidosis using placental stem cells
JP5841322B2 (en) 2010-04-22 2016-01-13 オレゴン ヘルス アンド サイエンス ユニバーシティ Fumaryl acetoacetate hydrolase (FAH) deficient pig and use thereof
CA2798895A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
JP5876045B2 (en) 2010-07-12 2016-03-02 ユニバーシティー オブ サザン カリフォルニア Biocompatible substrate that promotes interconnection of stem cells and target tissue and method of implanting the same
KR20130093091A (en) 2010-07-13 2013-08-21 안트로제네시스 코포레이션 Methods of generating natural killer cells
AU2011293440B2 (en) 2010-08-24 2016-05-05 Katholieke Universiteit Leuven Non-static suspension culture of cell aggregates
CN103354835B (en) 2010-12-08 2016-03-02 韦尔赛特公司 Reagents and methods for suppressing cell growth of human pluripotent stem
AR093183A1 (en) 2010-12-31 2015-05-27 Anthrogenesis Corp Increased power using placenta stem cell modulatory molecules arn
US20140370601A1 (en) 2011-03-23 2014-12-18 Minoru S.H. Ko Compositions and methods for enhancing the pluripotency of stem cells
WO2012149468A2 (en) 2011-04-29 2012-11-01 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
ES2707579T3 (en) 2011-06-01 2019-04-04 Celularity Inc Pain treatment using placental cytoblast
US20120308531A1 (en) 2011-06-06 2012-12-06 ReGenesys BVBA Expansion of Stem Cells in Hollow Fiber Bioreactors
GB201119335D0 (en) 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
AU2014215458A1 (en) 2013-02-05 2015-08-13 Anthrogenesis Corporation Natural killer cells from placenta
US20140322135A1 (en) 2013-04-30 2014-10-30 Katholieke Universiteit Leuven Cell therapy for myelodysplastic syndromes
WO2017210537A1 (en) 2016-06-02 2017-12-07 The Cleveland Clinic Foundation Complement inhibition for improving cell viability
WO2019070888A1 (en) 2017-10-03 2019-04-11 Children's Hospital And Clinics Of Minnesota Vectors and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
CA2247502A1 (en) 1996-02-28 1997-09-04 Vanderbilt University Compositions and methods of making embryonic stem cells
BR9711204A (en) * 1996-08-19 1999-08-17 Univ Massachusetts Strains of c-embriÄnicas cells are undifferentiated or similar produced by nuclear transplantation hybrid ESP-caries
DE19653685B4 (en) * 1996-12-13 2006-06-01 Institut für Pflanzengenetik und Kulturpflanzenforschung In vitro vascular smooth muscle cell system for pharmacological and physiological examinations
US6331406B1 (en) 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
US6280718B1 (en) * 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells

Also Published As

Publication number Publication date
WO2000027995A1 (en) 2000-05-18
JP2002529070A (en) 2002-09-10
US20050164383A1 (en) 2005-07-28
US20020160509A1 (en) 2002-10-31
EP1129176A1 (en) 2001-09-05
IL142748A (en) 2006-10-05
US6875607B1 (en) 2005-04-05
EP1129176A4 (en) 2002-10-30
CA2349415A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
DE69929036D1 (en) Endovaskuläre prothese
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE69924108D1 (en) Offshore-bohrsystem
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
GB2339200B (en) Genostics
DE69914898D1 (en) Formoterol-polymorphe
DE69916052D1 (en) Thermoformbare polypropylenschaumplatte
DE69918845D1 (en) Polyketonlösung
DE69942799D1 (en) Polyhydroxyalkanoatbiopolymere
DE69936586D1 (en) Redoxgelbatterie
DE69920742D1 (en) Intubationsvorrichtung
DE69919323D1 (en) Stillsitz
DE69940157D1 (en) Anthrax-impfstoff
DE69940641D1 (en) Ffe
DE69927618D1 (en) Scheibenenthaarungsvorrichtung
DE69934407D1 (en) Liver stem cells
DK1058724T3 (en) Maltogene alpha-amylase varianter
DE69905194D1 (en) Thermozykliergerät
DE69912952D1 (en) Cyclosporine
DE69913170D1 (en) Intubationsvorrichtung
DE69905170D1 (en) Thiazolopyrimidinderivate
GB9812768D0 (en) Methods
DE69942149D1 (en) Polyketide-synthese
GB9919776D0 (en) Compoujnds
HK1045694A1 (en) Pyrazol-carboxanilide fungizide

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed